Article Text

Download PDFPDF

Response to: ‘Association between proton pump inhibitors therapy and fracture risk in patients with rheumatoid arthritis’ by Lai et al
  1. Gulsen Ozen1,
  2. Kaleb Michaud1,2
  1. 1Department of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA
  2. 2Forward, The National Databank for Rheumatic Diseases, Wichita, Kansas, USA
  1. Correspondence to Dr Kaleb Michaud, Forward, The National Databank for Rheumatic Diseases, Wichita, KS 67214, USA; kmichaud{at}unmc.edu

Statistics from Altmetric.com

We appreciate Lai et al1 for sharing their data and emphasising the lack of association between proton pump inhibitor (PPI) use and fracture risk in a different patient population. We agree that the adverse association found with PPI use and fracture in the previous studies has not been repeated in many other well-designed studies. Our study has tested this association for …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles